AstraZeneca Prilosec OTC Launch Anticipated For Second Quarter 2001
This article was originally published in The Tan Sheet
Executive Summary
AstraZeneca's Prilosec proton pump inhibitor is anticipated to reach over-the-counter shelves in the second quarter of 2001.
You may also be interested in...
Prilosec 24-Hour Acid Control Would Be Unique To OTC Category
Once-a-day dosing of heartburn remedy Prilosec could be highlighted by AstraZeneca/Proctor & Gamble as a competitive advantage over other OTC stomach therapies if an Rx-to-OTC switch of the proton pump inhibitor were approved by FDA.
Prilosec 24-Hour Acid Control Would Be Unique To OTC Category
Once-a-day dosing of heartburn remedy Prilosec could be highlighted by AstraZeneca/Proctor & Gamble as a competitive advantage over other OTC stomach therapies if an Rx-to-OTC switch of the proton pump inhibitor were approved by FDA.
Prilosec 24-Hour Acid Control Would Be Unique To OTC Category
Once-a-day dosing of heartburn remedy Prilosec could be highlighted by AstraZeneca/Proctor & Gamble as a competitive advantage over other OTC stomach therapies if an Rx-to-OTC switch of the proton pump inhibitor were approved by FDA.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: